First published on The American Journal of Pathology, here is a noteworthy article for your Histopath industry news fix:
COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees of success to treat severe microbial infections for more than 100 years. Patients (n = 25) with severe and/or life-threatening COVID-19 disease were enrolled at the Houston Methodist hospitals from March 28 – April 14, 2020. Patients were transfused with convalescent plasma obtained from donors with confirmed SARS-CoV-2 infection and had recovered... Want to read more? View the entire article in The American Journal of Pathology Blog.
Working in the Histopathology industry and scouting for versatile Histopath lab equipment for your laboratory? Go through Lab.Equipment’s large collection of Histopathology equipment produced by globally recognized manufacturers like:
Get user-friendly and multi-function Histopath lab equipment for several histopath tests such as: